Generally the options available before the clinical trial are still available if the trial fails. The issues that must be discussed with your OC include drug interactions with residual drugs from the trial, immunology impacts, potential for SCT, etc. Remember a failing trial includes some patients that were never on the trial protocol (blind study) and may not be impacted by the failure at all. Please hold discussions with your OC, MM specialist, and those who ran the study. Best wishes!!

My present condition. Autologus Stemcell Transplant done on 25/11/24. Discharged from hospital on 15/12/24. Latest lab test IGG is about 3000. Maintenance: Bortizomib 2 mg every 15 days for 3 months. To meet Oncologist in 2nd week of May 2025. If u can provide email address, I can send all my latest reports thks

I see.
What about standard treatment for Myeloma such as Revlimid, Velcade, or Pomalyst? There are other options.

Hi, CART T cell therapy is very costly in India and I am from a middle class family, cannot afford the cost. During the last five years treatment all tge funds finished. Now fully depend on govt/charities. My childrens college/school study have also affected badly. Thks